AbbVie to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

AbbVie (NYSE: ABBV) will participate in the 10th Annual SVB Leerink Global Healthcare Conference on February 26, 2021. Key executives, including Michael Severino, Robert A. Michael, and Jeffrey R. Stewart, will present virtually at 9:40 a.m. CT. A live audio webcast will be available on AbbVie's Investor Relations website, with an archived session accessible later the same day. AbbVie focuses on developing innovative medicines across several therapeutic areas, including immunology, oncology, and neuroscience.

NORTH CHICAGO, Ill., Feb. 12, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 10^th Annual SVB Leerink Global Healthcare Conference on Friday, February 26. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present virtually at 9:40 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-10th-annual-svb-leerink-global-healthcare-conference-301227093.html

SOURCE AbbVie

FAQ

When is AbbVie presenting at the SVB Leerink Global Healthcare Conference?

AbbVie will present on February 26, 2021, at 9:40 a.m. Central time.

Who will represent AbbVie at the SVB Leerink Global Healthcare Conference?

Michael Severino, Robert A. Michael, and Jeffrey R. Stewart will represent AbbVie.

How can I access AbbVie's presentation at the conference?

The presentation will be available through AbbVie's Investor Relations website and archived later that day.

What is AbbVie's mission?

AbbVie's mission is to discover and deliver innovative medicines that address serious health issues.

What therapeutic areas does AbbVie focus on?

AbbVie focuses on immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology.